Information Technology·Semiconductors·$2.1B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.14 | N/A | N/A |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.14 | N/A | N/A |
| Revenue | N/A | N/A | N/A |
Tone: Defensive
Management expressed caution regarding future performance, highlighting market challenges. They did not provide any forward guidance.
Management did not provide specific revenue guidance for the upcoming quarters.
The company acknowledged ongoing challenges in the market.
Himax Technologies reported earnings with an EPS of $0.14, but did not disclose revenue figures. The stock fell by 1.42% following the report, likely due to the lack of guidance and the cautious tone from management regarding market conditions. Investors may be concerned about the company's future performance without clear direction.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
VERTEX PHARMACEUTICA
Feb 5, 2024